Skip to content

A comparative study of therapeutic effects of garlic and penicillamine in patients with chronic occupational lead poisoning

A comparative study of therapeutic effects of garlic and penicillamine in patients with chronic occupational lead poisoning

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138804062083N1
Enrollment
76
Registered
2010-06-19
Start date
2010-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lead poisoning. Toxic effects of lead and its compounds

Interventions

Intervention 1: Penicillamine Cap 250 mg 4 times daily for 4 weeks. Intervention 2: Garlic Tab 400 mg 4 times daily for 4 weeks (each tablet contains 1200 microgram allicin).
Treatment - Drugs
Penicillamine Cap 250 mg 4 times daily for 4 weeks
Garlic Tab 400 mg 4 times daily for 4 weeks (each tablet contains 1200 microgram allicin)

Sponsors

Research Department, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: employees who has worked more than one year in a car battery industry, blood lead levels of 200-500 µg/L Exclusion criteria: family history of allergy to penicillin and drugs that have cross-sensitivity to penicillin, antimalarial drugs and gold salt, history of agranolocytosis or anemia in previous use of penicillamine, known heart, liver or renal failure, hypersensitivity to garlic, hemorrhagic diathesis, elective surgery during and 10 days after the consumption of garlic, using antibiotics or anticoagulant drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood lead levels. Timepoint: Baseline and 1 month after the intervention. Method of measurement: by atomic absorption device, model Perkin Elmer 3030, through the technique of Heated Graphite Atomization.;Signs and symptoms. Timepoint: Baseline and 1 month after the intervention. Method of measurement: medical examination.

Secondary

MeasureTime frame
Side effects. Timepoint: routine medical examination to find possible abnormal signs and symptoms - Complete blood count 15 days after the initiation of intervention. Method of measurement: Routine medical examination - Complete blood count 15 days after the initation of treatment.;Blood sugar. Timepoint: Baseline and 1 month after the intervention. Method of measurement: laboratory testing.;Liid profile invluding (cholestrol, triglyceride, HDL and LDL). Timepoint: Baseline and one month after the intervention. Method of measurement: laboratory testing.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahdi Balali Mood

Medical Toxicology Center

mbalalimood@hotmail.com ; balalimoodm@mums.ac.ir+98 51 1859 8973

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026